Curis
CRIS | NASDAQ
$0.45
-$0.12 (-21.30%)
At close: Nov 13, 2026, 4:00 PM ET
$0.42
-$0.03 (-6.44%)
After-hours:
Nov 13, 2026, 7:56 PM ET
-21.30%
(1D)No price chart data available for 1D timeframe.
Rating
37.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #587/1022 (Top 57%)
Key Statistics
Market Data
Market Cap $961.16K
1D Range
0.43 0.50
52W Range
0.38 27.40
Valuation (TTM)
PE -0.03
PB 0.20
EV/EBITDA 0.17
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $43.00
Cash Flow
FCF Yield -3182.3%
SBC Adj. FCF Yield -3361.2%
SBC Impact -5.6%
Margins
Gross Margin 99.3%
Operating Margin -833.4%
FCF Margin -709.0%
Growth (CAGR)
Revenue 3Y | 5Y -24.9% |
-15.9%
Dil EPS 3Y | 5Y 81.7% |
39.3%
FCF 3Y | 5Y 17.6% |
12.2%
Returns
ROA -111.5%
ROE -1035.3%
ROIC -567.2%
Financial Health
Net Cash
$4.57M
Current Ratio 0.49
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Em...
Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Aug 1, 2000
Website www.curis.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$43.00
Upside
+9455.56%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CRIS